id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2026-P-2144-0003,FDA,FDA-2026-P-2144,Attachment 1,Supporting & Related Material,Background Material,2026-02-27T05:00:00Z,2026,2,,,2026-02-27T22:06:13Z,,0,0,09000064b91e2fca
FDA-2026-P-2144-0005,FDA,FDA-2026-P-2144,Attachment 3,Supporting & Related Material,Background Material,2026-02-27T05:00:00Z,2026,2,,,2026-02-27T22:06:19Z,,0,0,09000064b91e2fcc
FDA-2026-P-2144-0002,FDA,FDA-2026-P-2144,"Acknowledgement Letter from FDA DMB to Hyman, Phelps & McNamara, P.C.",Other,Acknowledgement Letter/Receipt,2026-02-27T05:00:00Z,2026,2,2026-02-27T05:00:00Z,,2026-02-27T22:06:07Z,,0,0,09000064b91e3859
FDA-2026-P-2144-0001,FDA,FDA-2026-P-2144,"Suitability Petition from Hyman, Phelps & McNamara, P.C.",Other,Petition(s),2026-02-27T05:00:00Z,2026,2,2026-02-27T05:00:00Z,,2026-02-27T22:05:51Z,,1,0,09000064b91e3853
FDA-2026-P-2144-0004,FDA,FDA-2026-P-2144,Attachment 2,Supporting & Related Material,Background Material,2026-02-27T05:00:00Z,2026,2,,,2026-02-27T22:06:16Z,,0,0,09000064b91e2fcb